RVX-208

RVX-208 is a small molecule which can act as a BET bromodomain inhibitor. It is provided as a powder.

This product acts on the following target types: Bromodomain.
This product acts on the following biochemical pathways: Cholesterol metabolism, Chromatin, Posttranslational modification.
This product may be of interest in the following research areas and diseases: Epigenetics, Atherosclerosis.
This product may act as a Coronavirus inhibitor: SARS-CoV-2 transmembrane protein E binds to the bromodomain-containing proteins BRD2 and BRD4.

Please note that our chemical products are for scientific research use only in a laboratory and are not for medical or veterinary use. This product can only be dispatched to a scientific business or laboratory address.

Target	RVX-208
Form	Solid
Purity	> 98%
Reconstitution	Soluble in DMSO (up to 75 mg/ml) or in Ethanol (up to 4 mg/ml).
Storage	Store desiccated at -20 °C for up to 1 year. Solutions can be stored at -20 °C for up to 1 month.
Molecular Weight	370.4 g/mol
Molecular Formula	C20H22N2O5
Buffer	Not applicable.
CAS Number	1044870-39-4
Availability	Shipped within 5-10 working days.
Note	THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.

Research Articles on RVX-208

Write a review

Your Name

Your Email Address

PMID

DOI

Your Review

Rating

Continue